Glucose metabolism is controlled by non-coding RNAs in autoimmune diseases; a glimpse into immune system dysregulation
Raed Obaid Saleh,
No information about this author
Raed Fanoukh Aboqader Al-Aouadi,
No information about this author
Nujud Almuzaini
No information about this author
et al.
Human Immunology,
Journal Year:
2025,
Volume and Issue:
86(3), P. 111269 - 111269
Published: Feb. 24, 2025
Language: Английский
Advances in RNA therapy for the treatment of autoimmune diseases
Autoimmunity Reviews,
Journal Year:
2025,
Volume and Issue:
unknown, P. 103753 - 103753
Published: Jan. 1, 2025
Language: Английский
Exosomes derived let-7f-5p is a potential biomarker of SLE with anti-inflammatory function
Yi‐Jing Liu,
No information about this author
Hai-bing Miao,
No information about this author
Shu Lin
No information about this author
et al.
Non-coding RNA Research,
Journal Year:
2025,
Volume and Issue:
12, P. 116 - 131
Published: Feb. 22, 2025
Language: Английский
Biological functions and affected signaling pathways by Long Non-Coding RNAs in the immune system
Hossein Ghahramani Almanghadim,
No information about this author
Bahareh Karimi,
No information about this author
Sepehr Valizadeh
No information about this author
et al.
Non-coding RNA Research,
Journal Year:
2024,
Volume and Issue:
10, P. 70 - 90
Published: Sept. 6, 2024
Language: Английский
Regulation of IFNβ expression: focusing on the role of its promoter and transcription regulators
Jiqiang Fan,
No information about this author
Qiumei Li,
No information about this author
Jiadi Liang
No information about this author
et al.
Frontiers in Microbiology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 15, 2023
IFNβ
is
a
single-copy
gene
without
an
intron.
Under
normal
circumstances,
it
shows
low
or
no
expression
in
cells.
It
upregulated
only
when
the
body
needs
stimulated.
Stimuli
bind
to
pattern
recognition
receptors
(PRRs)
and
pass
via
various
signaling
pathways
several
basic
transcriptional
regulators,
such
as
IRFs,
NF-кB,
AP-1.
Subsequently,
regulators
enter
nucleus
regulatory
elements
of
promoter.
After
modifications,
position
nucleosome
altered
complex
assembled
activate
expression.
However,
regulation
involves
network.
For
study
immunity
diseases,
important
understand
how
transcription
factors
through
specific
forms,
which
cells
are
involved
regulation,
what
occurs
during
assembly
enhancers
complexes,
possible
mechanisms
after
transcription.
Thus,
this
review
focuses
on
activation
In
addition,
we
discuss
impact
biology.
Language: Английский
Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1
Pathology - Research and Practice,
Journal Year:
2023,
Volume and Issue:
254, P. 155041 - 155041
Published: Dec. 20, 2023
Language: Английский
LÚPUS ERITEMATOSO SISTÊMICO: CRITÉRIOS DIAGNÓSTICOS E OPÇÕES TERAPÊUTICAS
Diogo Uechi Fukuda Okoti,
No information about this author
Leylinda Fernanda de Sousa Leopoldino Dantas,
No information about this author
Larissa Linhares Santos
No information about this author
et al.
Revista Contemporânea,
Journal Year:
2024,
Volume and Issue:
4(6), P. e4884 - e4884
Published: June 27, 2024
O
Lúpus
Eritematoso
Sistêmico
(LES)
é
uma
doença
autoimune
complexa
que
acomete
sortidas
partes
do
organismo.
Há
o
desencadeamento
de
inflamação
e
dano
tecidual.
A
prevalência
eminente
no
sexo
feminino,
em
afrodescendentes,
hispânicos
asiáticos.
diagnóstico
LES
se
baseia
critérios
clínicos,
laboratoriais
imunológicos,
sendo
fundamental
para
iniciar
tratamento
adequado
prevenir
complicações
graves.
multidisciplinar
visa
controle
sintomático,
a
redução
da
proteção
dos
tecidos
acometidos.
Esta
análise
sistemática
literatura
averiguou
pesquisas
publicadas,
nos
últimos
5
anos,
inerentes
conduta
LES.
Os
inclusão
abrangeram
estudos
humanos,
múltiplos
idiomas,
resultando
na
seleção
13
relevantes.
Destacam-se:
classificação,
biomarcadores
genéticos,
terapia
com
células-tronco
mesenquimais
novas
opções
terapêuticas.
Perspectivas
positivas
são
avanços
terapêuticos.
Entretanto,
revelou
gaps
compreensão
patologia,
desse
modo,
há
necessidade
futuros
mais
refinados
elucidação
adequada.
Unveiling Urinary Biomarkers, Crucial Genes, and Immune Infiltration in Lupus Nephritis Patients
Huiqiong Zeng,
No information about this author
Zhongyu Xie,
No information about this author
Haofei Hu
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 17, 2023
Abstract
Background
This
study
was
conducted
to
investigate
the
expression
patterns
and
biological
roles
of
urinary
long
non-coding
RNAs
(lncRNAs)
messenger
(mRNAs)
in
individuals
diagnosed
with
lupus
nephritis
(LN).
Methods
The
cohort
comprised
six
participants:
three
systemic
erythematosus
(SLE)
involving
LN,
SLE
without
healthy
controls
(CON).
Microarray
technology
employed
analyze
mRNAs
lncRNAs,
thereby
exploring
alterations
overall
RNA
expression.
Functional
insights
into
dysregulated
differentially
expressed
(DEMs)
associated
LN
were
derived
through
gene
ontology
(GO)
enrichment
analysis,
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
set
analysis
(GSEA).
Furthermore,
construction
a
protein-protein
interaction
(PPI)
network
accomplished
using
Search
Tool
for
Retrieval
Interacting
Genes/Proteins
(STRING).
identification
immune-related
cell
types
facilitated
by
Single-sample
Gene
Set
Enrichment
Analysis
(ssGSEA).
To
predict
potential
drug
candidates
based
on
genes
(DEGs),
Connectivity
Map
(CMap)
conducted.
Results
Within
urine
samples
patients,
total
247
602
lncRNAs
exhibited
differential
relative
control
group.
Among
these,
83
down-regulated
141
up-regulated
DEMs
specifically
discerned
patients
LN.
GO
highlighted
processes
such
as
transcriptional
regulation,
intrinsic
apoptotic
signaling
pathways
response
DNA
damage,
regulation
mitophagy.
KEGG
primarily
revealed
protein
processing
within
endoplasmic
reticulum,
apoptosis,
P53
pathway.
Co-expression
PPI
suggested
that
nodes
higher
degrees
connectivity
concentrated
related
apoptosis
autophagy.
An
assessment
immune
infiltration
unveiled
correlation
between
activated
B
cells
CD56
dim
natural
killer
(NK)
pathogenesis.
prediction
drugs
implicated
inhibition
mechanistic
Aurora
kinase
A
(
AURKA
)
primary
targeted
intervention.
molecular
docking
process
confirmed
robust
binding
activity
hub
genes'
components.
Conclusion
has
illuminated
distinct
profiles
(LN)
patients.
These
profiles,
particularly
context
autophagy,
involvement,
provide
valuable
LN's
underlying
mechanisms.
therapeutic
targets,
,
offers
promising
directions
future
interventions
management.
Language: Английский